Multiple Comparisons in Clinical Trials

Feedback from 2010 Event
-  "It was a wonderful, successful event in this special area." - Jie X. Chen, PhD, Director of Statistics, Global Surveillance & Pharmaco-epidemiology, Abbott Laboratories

Clinical trials give rise to enormous amount of data, both on efficacy and safety. As a result, the findings from these trials should be treated with caution and application of statistical methodologies should be defined upfront to prevent inflation of type 1 error, while maximizing power. The focus of this meeting is to describe and discuss recent developments of methods for handling multiple comparisons, with specific applications in clinical trials. Areas covered include among others:

  • Multiple dose comparisons
  • Comparisons with a control
  • Multiple Endpoint Comparisons
  • Interim analyses
  • Multiple Subset Comparisons

Who should Attend

Executives from Drug, Biologic and Medical Device Companies working in any of the following departments:

  • Statistics/Biostatistics/Biometrics
  • Safety & Risk Management/Operations
  • Pharmacovigilance
  • Clinical Operations/Development/Research
  • Medical Affairs
  • Regulatory Affairs

Conference is also of interest to:

  • Statistical Analysis Companies
  • Data Management Services
  • Contract Research Organizations
  • Regulatory Agencies
  • Academics
  • IRBs
  • Law Firms
  • Statisticians